Medtronic
MDTMedtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services.
Earnings
Next report
Nov 17, 2026 (in a month)Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
Profile
Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services. The company focuses on alleviating pain and restoring health through biomedical engineering, integrating artificial intelligence and data analytics to personalize patient care. It operates a vast distribution network serving healthcare systems and physicians in more than 150 countries.
A leading global healthcare technology company characterized by a massive R&D pipeline and a dominant presence in cardiovascular and surgical robotics markets.
FAQ
- What is Medtronic's market cap?
- Medtronic (MDT) has a market capitalization of $112.24B and trades on NYSE.
- What is Medtronic's revenue and profitability?
- Medtronic generated $37.5B in trailing twelve-month revenue with net income of $5.2B, representing a net margin of 13.9%. Gross margin stands at 65.0%, with free cash flow of $6.1B. The latest reported period is Q1 2027.
- Who are Medtronic's competitors?
- Medtronic's key competitors include Stryker Corporation, Boston Scientific, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Medtronic have?
- Medtronic's subsidiaries include Mazor Robotics, Affera.
- Where is Medtronic headquartered?
- Medtronic is headquartered in Ireland and employs approximately 95,000 people. It has been publicly traded since 1972.
